Skip to content

Starting HAART with a CD4 cell count below 100 cells/mm3 a risk factor for IRIS, study finds

A quarter of US women stop HAART within five years

Late HIV diagnosis common in British gay men and linked to increased mortality

Seroreversion possible, but rare, after early treatment of acute HIV infection

First randomised study of treatment in primary HIV infection begins recruitment

AIDS events with a viral cause decline most steeply after starting HAART

Long-term CD4 increase on HAART averages 250-350 cells, plateaus after 3-4 years

Low weight in women a risk factor for severe nevirapine liver toxicities

Routine HIV testing clinically and economically justified, and would cut spread of HIV, say US researchers